Selank for ADHD and anxiety: what the science actually shows
Quick answer
Selank is a synthetic heptapeptide analog of the immunomodulatory peptide tuftsin, studied primarily in Russian clinical trials for generalized anxiety disorder and neurasthenia, with the strongest human data involving intranasal administration over short durations in supervised settings. It has not been approved by the FDA, has no published controlled trial data in ADHD populations, and is not available as a standardized pharmaceutical in the United States. Women experiencing anxiety or cognitive changes in perimenopause should undergo a formal clinical evaluation before attributing symptoms to conditions that a peptide can address.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 8 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Selank for ADHD and anxiety: what the science actually shows, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Functional Connectomic Approach to Studying Selank and Semax Effects
Small Russian fMRI study (52 healthy volunteers) of brain connectivity after Semax or Selank; mechanistic and exploratory, not a clinical efficacy trial.
PubMed
Effects of Semax on the Default Mode Network of the Brain
Small human fMRI study (24 adults) of intranasal Semax on brain networks; an imaging-marker study with no clinical outcomes, not replicated outside the originating group.
PubMed
Understanding weight gain at menopause
Background source for body-composition and weight-change discussions around menopause.
PubMed
Management of obesity in menopause
Current source for menopause-specific obesity management framing.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
Selank for ADHD and anxiety: what the science actually shows is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.
Helpful context before the funnel
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "Selank for ADHD and anxiety: what the science actually shows" from ๐ Gem C ๐. We read the clip as a Peptide social video fact-checks claim about Peptide social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: Selank is a synthetic heptapeptide analog of the immunomodulatory peptide tuftsin, studied primarily in Russian clinical trials for generalized anxiety disorder and neurasthenia, with the strongest human data involving intranasal administration over short durations in supervised settings.
The reason this review is not generic is the source wording and the canonical claim label "peptides my experience so far on selank biohacking womenover40 adhdti." In this clip, the useful excerpt is: "My experience so far on Selank." That wording changes the review because it points to Peptide social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.
The source trail for this page is checked against Functional Connectomic Approach to Studying Selank and Semax Effects (2020), Effects of Semax on the Default Mode Network of the Brain (2018), and Therapeutic Peptides: Applications, Challenges, and Future Directions (2026), plus the creator's own wording. Peptide social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
Selank is a synthetic heptapeptide analog of the immunomodulatory peptide tuftsin, studied primarily in Russian clinical trials for generalized anxiety disorder and neurasthenia, with the strongest human data involving intranasal administration over short durations in supervised settings.
FormBlends verdict
Peptide social video fact-checks evidence, safety, and patient-fit context
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- Selank is a synthetic heptapeptide analog of the immunomodulatory peptide tuftsin, studied primarily in Russian clinical trials for generalized anxiety disorder and neurasthenia, with the strongest human data involving intranasal administration over short durations in supervised settings. It has not been approved by the FDA, has no published controlled trial data in ADHD populations, and is not available as a standardized pharmaceutical in the United States. Women experiencing anxiety or cognitive changes in perimenopause should undergo a formal clinical evaluation before attributing symptoms to conditions that a peptide can address.
- Selank has real but limited human trial data, primarily from small Russian studies in the early 2000s examining anxiety disorders, not ADHD.
- The anxiolytic effect in Semenova et al. (2010) was measured at 400 mcg intranasal daily over 14 days in clinically supervised conditions, not self-administered protocols from online communities.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Selank has real but limited human trial data, primarily from small Russian studies in the early 2000s examining anxiety disorders, not ADHD.
- The anxiolytic effect in Semenova et al. (2010) was measured at 400 mcg intranasal daily over 14 days in clinically supervised conditions, not self-administered protocols from online communities.
- No published clinical trial has studied Selank specifically in an ADHD population. The ADHD framing on social media is anecdotal.
- Compounded or gray-market Selank sold to consumers is not the same standardized formulation used in clinical research, and purity is unverified.
- Women over 40 experiencing anxiety, brain fog, or attention issues should get a hormonal panel and formal evaluation before attributing those symptoms to something a peptide can fix.
- Selank acts on GABAergic and serotonergic pathways and is pharmacologically active. Describing it as side-effect-free or inert is inaccurate.
- Selank is not FDA-approved for any indication and is not available as a regulated pharmaceutical in the United States.
Our take ยท Written by FormBlends editorial team ยท Reviewed by FormBlends Medical Team ยท This is not a transcript. It is our independent review of the video above.
What's this video probably claiming?
Based on the caption, hashtags, and the creator's apparent audience of women over 40 interested in biohacking, this video almost certainly covers a personal experience using Selank, a synthetic heptapeptide derived from tuftsin. The ADHD hashtag suggests the creator is framing Selank as something that helped her focus, reduced anxiety, or served as an alternative or adjunct to traditional ADHD treatment. The biohacking tag signals she's likely presenting this as a self-directed experiment rather than clinically supervised therapy. Expect claims about reduced brain fog, calmer mood, better concentration, or improved sleep, possibly within the first few days of use. She may also reference dosing protocols circulating in peptide communities, such as intranasal administration, and frame her results as a discovery other women in her demographic should know about. We'll verify specific claims in Phase 2 once the transcript is available.
What does the science actually show?
Selank (TP-7) was developed by the Institute of Molecular Genetics of the Russian Academy of Sciences and has been studied primarily in Russian clinical literature, which creates an immediate reproducibility problem. The strongest human data comes from Semenova et al. (2010, Bulletin of Experimental Biology and Medicine), which found intranasal Selank at 400 mcg daily over 14 days reduced anxiety scores in patients with generalized anxiety disorder and neurasthenia. A separate controlled study by Zozulya et al. (2001, same journal) reported anxiolytic effects comparable to medazepam without the sedation or dependency profile. Animal data suggests modulation of GABA-A receptor activity and upregulation of BDNF. None of this research was conducted on ADHD specifically. The doses used in human trials were controlled and supervised. No large-scale randomized controlled trials exist in Western peer-reviewed literature, and no FDA review has been conducted. The evidence base is real but narrow, old, and geographically limited.
Where does the social media noise diverge from clinical reality?
The gap here is significant. TikTok's Selank community tends to present it as a clean, side-effect-free nootropic that works in days, is ideal for women with hormonal anxiety, and is somehow safer than prescription options because it's a peptide. None of those framings hold up cleanly. First, Selank's mechanisms involve GABAergic and serotonergic pathways, meaning it is pharmacologically active, not inert. Second, the ADHD framing is almost entirely anecdotal. No published study has examined Selank in an ADHD population. Third, compounded intranasal Selank available through peptide vendors or gray-market suppliers is not the same formulation used in Russian clinical trials, and purity is unverified. The womenover40 framing adds another layer of concern: perimenopause involves genuine hormonal shifts that affect anxiety and cognition, and self-treating those symptoms with unregulated peptides, rather than getting a proper hormonal workup, could delay appropriate care. Enthusiasm in the biohacking community consistently outpaces the data.
What should you actually know?
Selank has a more credible preliminary evidence base than many peptides circulating on TikTok. That's worth acknowledging. The anxiolytic data is real, even if it's limited to small Russian trials from the early 2000s. But there are things you should not walk away believing. Selank is not an approved treatment for anxiety or ADHD in the United States. Intranasal peptides have variable bioavailability depending on formulation, and what's sold by compounders or research chemical vendors is not standardized. If you are a woman over 40 experiencing anxiety, cognitive changes, or attention difficulties, those symptoms have known, evidence-backed diagnostic pathways including hormonal panels, ADHD evaluation, and sleep studies. Using Selank as a first-line self-experiment skips all of that. If you are working with a telehealth provider on a supervised peptide protocol, that is a different conversation than buying Selank online because a TikTok creator had a good week. The personal experience framing, while honest, is a sample size of one.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
๐ Gem C ๐ ยท TikTok creator
14.9K views on this video
My experience so far on Selank. #biohacking #womenover40 #adhdtiktok #selank
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about selank has real?
Selank has real but limited human trial data, primarily from small Russian studies in the early 2000s examining anxiety disorders, not ADHD.
What does the video say about the anxiolytic effect in semenova et al. (2010) was measured?
The anxiolytic effect in Semenova et al. (2010) was measured at 400 mcg intranasal daily over 14 days in clinically supervised conditions, not self-administered protocols from online communities.
What does the video say about no published clinical trial has studied selank specifically in an?
No published clinical trial has studied Selank specifically in an ADHD population. The ADHD framing on social media is anecdotal.
What does the video say about compounded?
Compounded or gray-market Selank sold to consumers is not the same standardized formulation used in clinical research, and purity is unverified.
What does the video say about women over 40 experiencing anxiety, brain fog,?
Women over 40 experiencing anxiety, brain fog, or attention issues should get a hormonal panel and formal evaluation before attributing those symptoms to something a peptide can fix.
What does the video say about selank acts on gabaergic?
Selank acts on GABAergic and serotonergic pathways and is pharmacologically active. Describing it as side-effect-free or inert is inaccurate.
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by ๐ Gem C ๐, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.